Synlogic Inc
NASDAQ:SYBX 4:00:00 PM EDT
Market Cap (Intraday) | 20.85M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $1.80 |
50-Day MA | $2.31 |
200-Day MA | $4.22 |
Synlogic Inc Stock, NASDAQ:SYBX
301 Binney Street, Suite 402, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.401.9975
Number of Employees: 6
Description
Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on December 20, 2007 and is headquartered in Cambridge, MA.